Menu

Synthetic Sausages

Meat cultured from stem cells in the lab may hit the market in the next year.

Sep 2, 2011
Jef Akst

WIKIMEDIA COMMONS, SALIMFADHLEY

No pigs or cows required—meat grown in the lab from cultured stem cells may be hitting the market sooner than one might guess. Earlier this week, researchers gathered in Sweden to discuss the progress towards generating slaughter-less meat. The conclusion: lab-grown sausages may be as little as 6 months away, according to Mark Post of Maastricht University in the Netherlands, who recently succeeded in growing pig muscle in the lab.

Researchers tout the impending success as one that could save millions of animal lives as well as be more environmentally friendly and energy efficient than current animal farming practices.

But a major hurdle remains: will the meat be as tasty and nutritious as the real thing? Though Post subjects his lab-grown meat to exercise on a daily basis—by anchoring it to Velcro and literally stretching the cells—to ensure it bulks up as much as it would on a living animal, the meat is still, for lack of a better word, unappetizing—namely because it has no blood, Post told New Scientist. “It's white because there's no blood in it, and very little myoglobin, the iron-bearing protein," he said. "We are looking at ways to build up the myoglobin content to give it colour."

And he next plans to turn to beef. "I'm hopeful we can have a hamburger in a year," Post told New Scientist.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.